Tata Institute comes up with a ₹100 drug to prevent cancer recurrence; doctors to start human trials soon

Researchers at the Tata Institute in Mumbai say they've developed a tablet aimed at preventing cancer recurrence. After 10 years of research, they believe that the drug will help prevent cancer from recurring in patients for a second time

from mint - science https://ift.tt/HiauNl1
https://ift.tt/478ZPgB